|
DGAP-News: Deciphera Pharmaceuticals, Inc.
/ Key word(s): Regulatory Approval
Deciphera Receives European Commission Approval of QINLOCK(R) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor 22.11.2021 / 13:52 The issuer is solely responsible for the content of this announcement. |
1250978 22.11.2021
COMTEX_397436375/2560/2021-11-22T07:54:01
Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.
